Body
Death rates for breast cancer have declined over the last several decades, and the United States is home to more than 3.1 million survivors. Yet more than 20 percent of these survivors experience what is colloquially referred to as “chemo brain” or “chemo fog,” a cognitive condition affecting thinking, perception and communication that often goes undiagnosed and untreated. Now, researchers at the Rehabilitation Institute of Chicago (RIC) are proposing a comprehensive set of screening instruments to address cognitive impairments related to this phenomenon.
In a new study published in the journal Current Breast Cancer Reports, Leora Cherney, PhD, a senior research scientist at RIC and professor at the Northwestern University Feinberg School of Medicine, and Diane F. Morean, PhD, a postdoctoral fellow at RIC and Feinberg, outline a standardized approach for screening using online tools that are free and widely available.
Read the full story at the link below.